GlassScriptPhysician profile
Elio Vento
NPI 1487717492
$1,628.67
in general payments reported to CMS, 2019-2025
15 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.21 · 2020: $194 · 2021: $420 · 2022: $130 · 2023: $376 · 2024: $217 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851 · Education: $15.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.52 |
| Education | $15.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $299.97 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $268.79 | 2020-2024 | Spravato |
| Pfizer INC. | $219.52 | 2021-2025 | |
| Abbvie INC. | $219.33 | 2022-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $168.33 | 2023-2025 | Kisunla, Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $147.96 | 2020-2023 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $95.34 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $50.75 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $45.41 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $36.07 | 2021 | |
| Amneal Pharmaceuticals LLC | $18.26 | 2024 | Unithroid |
| Horizon Therapeutics Plc | $17.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.94 | 2023 | Abilify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.27 | 2020 | |
| Eisai INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elio Vento listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.